A Randomized, Double-blinded, Placebo-controlled, Crossover, Add-on Study Of CoEnzyme Q10 In The Prevention Of Pediatric And Adolescent Migraine
Notes for this study:
|Number of Subjects
||1-6, 7-12, 13-17
In children and adolescents, CoQ10 supplementation reduced migraine and headache frequency significantly during weeks 1-4 of the trial, to a greater extent than placebo. In the latter portions of the trial, there were no differences between CoQ10 and Placebo.
CoQ10 was administered at 100mg daily.